Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.

Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF.

J Immunol. 2002 Jul 15;169(2):1102-9.

2.

Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.

Zhou SF, Xie XX, Bin YH, Lan L, Chen F, Luo GR.

Clin Chim Acta. 2006 Apr;366(1-2):274-80. Epub 2005 Dec 13.

PMID:
16356486
3.
4.

HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma.

Li B, Qian XP, Pang XW, Zou WZ, Wang YP, Wu HY, Chen WF.

Lab Invest. 2003 Aug;83(8):1185-92.

PMID:
12920247
5.

Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues.

Yang XA, Dong XY, Qiao H, Wang YD, Peng JR, Li Y, Pang XW, Tian C, Chen WF.

Lab Invest. 2005 Feb;85(2):205-13.

6.

[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].

Wang WX, Leng XS, Peng JR, Mu DC, Wang Y, Zhu JY, Du RY, Chen WF.

Zhonghua Wai Ke Za Zhi. 2003 Jul;41(7):506-8. Chinese.

PMID:
12921655
7.

Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.

Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM, Tan EM.

Am J Pathol. 1992 Apr;140(4):859-70.

8.

Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.

Wang K, Xu X, Nie Y, Dai L, Wang P, Zhang J.

Cancer Lett. 2009 Aug 28;281(2):144-50. doi: 10.1016/j.canlet.2009.02.037. Epub 2009 Mar 21.

PMID:
19304375
9.

Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.

Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.

Int J Oncol. 2006 Aug;29(2):315-27.

PMID:
16820872
10.

Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.

Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T, Shiratori Y.

Cancer. 2003 May 15;97(10):2474-9.

11.

Definition of tumor-associated antigens in hepatocellular carcinoma.

Stenner-Liewen F, Luo G, Sahin U, Tureci O, Koslovski M, Kautz I, Liewen H, Pfreundschuh M.

Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):285-90.

13.

Novel tumor-associated antigen of hepatocellular carcinoma defined by monoclonal antibody E4-65.

Zou K, Ju J, Xie H.

Acta Biochim Biophys Sin (Shanghai). 2007 May;39(5):359-65.

14.
15.

Changes in the expression of sialyl-Lewisx, a hepatic necroinflammation-associated carbohydrate neoantigen, in human hepatocellular carcinomas.

Okada Y, Jin-no K, Ikeda H, Sakai N, Sotozono M, Yonei T, Nakanishi S, Moriwaki S, Tsuji T.

Cancer. 1994 Apr 1;73(7):1811-6.

16.

Enhanced expression of a new class of liver-enriched b-Zip transcription factors, hepatocarcinogenesis-related transcription factor, in hepatocellular carcinomas of rats and humans.

Kishimoto T, Kokura K, Ohkawa N, Makino Y, Yoshida M, Hirohashi S, Niwa S, Muramatsu M, Tamura T.

Cell Growth Differ. 1998 Apr;9(4):337-44.

17.

Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.

Chen X, Fu S, Chen F, Chen H, Chen Z.

Oncol Rep. 2008 Oct;20(4):979-85.

PMID:
18813843
18.

TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma.

Yin YH, Li YY, Qiao H, Wang HC, Yang XA, Zhang HG, Pang XW, Zhang Y, Chen WF.

Br J Cancer. 2005 Aug 22;93(4):458-63.

19.

A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.

Somers VA, Brandwijk RJ, Joosten B, Moerkerk PT, Arends JW, Menheere P, Pieterse WO, Claessen A, Scheper RJ, Hoogenboom HR, Hufton SE.

J Immunol. 2002 Sep 1;169(5):2772-80.

20.
Items per page

Supplemental Content

Write to the Help Desk